Breakthrough Study Identifies Genetic Link to Rare Bladder Disease

Researchers at the University of Tokyo headed by Yoshiyuki Akiyama have made a remarkable discovery about a puzzling and rare bladder disease called Hunner-type interstitial cystitis (HIC). This chronic and inflammatory condition affects the urinary bladder and has long remained a mystery due to its unknown cause and genetic background. However, through a groundbreaking study,…

Read More

Genetic Insights Symposium 2023

Join us for an exciting event at Claritas Genomics, where we will be hosting the groundbreaking “Genetic Insights Symposium.” This symposium will bring together leading researchers, geneticists, and scientists from around the world to share their latest discoveries and insights in the field of genetics. The symposium will take place in the Genetics Laboratory at…

Read More

Synthetic Minimal Cell Demonstrates Evolutionary Adaptability

In a groundbreaking study conducted by evolutionary biologist Jay T. Lennon and his team at Indiana University Bloomington, the remarkable adaptability of life has been demonstrated once again. Lennon’s research focused on a synthetically constructed minimal cell that possessed only the essential genes for survival. Surprisingly, the team discovered that this streamlined cell was capable…

Read More

Genomix Conference 2023: A Premier Online Event Showcasing the Latest Advancements in Genomics

Cambridge, June 30, 2023 – Claritas Genomics Laboratory is thrilled to announce the highly anticipated Genomix Conference 2023, an exceptional online event set to take place from September 1 to September 3, 2023. This groundbreaking conference is designed to convene esteemed experts, distinguished researchers, and industry professionals from across the globe, fostering collaboration and knowledge…

Read More

Claritas Genomics Laboratory Implements State-of-the-Art Fluidigm Biomark High-Performance PCR System

Cambridge, June 6, 2023 – Claritas Genomics Laboratory, a leading provider of genetic testing and diagnostics, proudly announces the integration of the advanced Fluidigm Biomark high-performance PCR system into its state-of-the-art facility. This cutting-edge technology is set to revolutionize genetic diagnostics and further enhance Claritas Genomics’ precision in identifying and analyzing genetic disorders. Fluidigm Biomark:…

Read More

A Tool Unveiling the Mechanism Behind COVID-19 Susceptibility and Beyond

Researchers at the Wellcome Sanger Institute, in collaboration with partners in Japan and Tel Aviv University, have developed a groundbreaking tool called GASPACHO (GAuSsian Processes for Association mapping leveraging Cell HeterOgeneity). This innovative tool aims to investigate the susceptibility to COVID-19 by capturing dynamic changes in gene expression during the innate immune response. Through GASPACHO,…

Read More